MegaPro Biomedical Co., Ltd (6827.TWO)
TWD 9.0
(-2.7%)
TWD 9.0
(-2.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 18 Thousand | - | - | 7.42 Million | - |
| Cost of Revenue | 16.61 Million | - | - | - | - |
| Gross Profit | -16.6 Million | - | - | 7.42 Million | - |
| Operating Expenses | 18 Thousand | 121.74 Million | 100.97 Million | 156.75 Million | -178.33 Million |
| Selling, General and Administrative Expenses | 24.55 Million | 20.82 Million | 15.41 Million | 9.72 Million | - |
| Research and Development Expenses | 115.95 Million | 100.91 Million | 85.56 Million | 147.03 Million | - |
| Other Expenses | - | 8.23 Million | 10.71 Million | -1.85 Million | -178.33 Million |
| Cost and Expenses | 140.5 Million | 121.74 Million | 100.97 Million | 156.75 Million | -178.33 Million |
| Operating Income | -127.25 Million | -110.91 Million | -89.15 Million | -149.32 Million | -178.33 Million |
| Interest Expense | 295 Thousand | 371 Thousand | - | - | - |
| Income Tax Expense | -4000.00 | 436 Thousand | - | - | - |
| Earnings before Tax | -127.55 Million | -111.28 Million | -89.15 Million | -148.86 Million | - |
| Net Income | -127.54 Million | -111.72 Million | -89.15 Million | -148.86 Million | - |
| Earnings Per Share Basic | -2.46 | -2.02 | -1.65 | -2.90 | -3.57 |
| Earnings Per Share Diluted | -2.46 | -2.02 | -1.65 | -2.90 | -3.57 |
| Weighted Average Shares Outstanding | 51.86 Million | 55.39 Million | 54.07 Million | 51.26 Million | 48.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 51.86 Million | 55.39 Million | 54.07 Million | 51.26 Million | 48.76 Million |
| Gross Margin | -922.28 | - | - | 1.00 | - |
| EBIT Margin | -6146.56 | - | - | -19.29 | - |
| Profit Margin | -7086.00 | - | - | -20.04 | - |
| EBITDA | -110.63 Million | -97.35 Million | -81.61 Million | -143.31 Million | -178.33 Million |
| Earnings Before Tax Margin | -7069.83 | - | - | -20.10 | - |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 14 Thousand | 18 Thousand | 18 Thousand | - | - | - |
| Cost of Revenue | 8.62 Million | 8.34 Million | - | 8.27 Million | - | 7.8 Million |
| Gross Profit | -8.6 Million | -8.32 Million | 18 Thousand | -8.27 Million | - | -7.8 Million |
| Operating Expenses | 79.65 Million | 67.36 Million | 140.5 Million | 56.51 Million | 121.74 Million | 45.57 Million |
| Selling, General and Administrative Expenses | 5.35 Million | 3.67 Million | - | 4.25 Million | - | 6.11 Million |
| Research and Development Expenses | 74.29 Million | 63.69 Million | - | 52.26 Million | - | 47.09 Million |
| Other Expenses | - | - | 8.43 Million | - | 8.23 Million | 7.64 Million |
| Cost and Expenses | 88.27 Million | 75.71 Million | 140.5 Million | 64.79 Million | 121.74 Million | 53.37 Million |
| Operating Income | -88.26 Million | -75.69 Million | -127.25 Million | -64.79 Million | -110.91 Million | -53.37 Million |
| Interest Expense | 351 Thousand | 138 Thousand | 295 Thousand | 157 Thousand | 371 Thousand | 176 Thousand |
| Income Tax Expense | 11.37 Million | -4000.00 | -4000.00 | 2.93 Million | 436 Thousand | 436 Thousand |
| Earnings before Tax | -77.23 Million | -65 Million | -127.55 Million | -62.24 Million | -111.28 Million | -49 Million |
| Net Income | -77.23 Million | -65.07 Million | -127.54 Million | -62.47 Million | -111.72 Million | -49.44 Million |
| Earnings Per Share Basic | -1.29 | -1.06 | - | -1.06 | - | -0.80 |
| Earnings Per Share Diluted | -1.29 | -1.06 | - | -1.06 | - | -0.80 |
| Weighted Average Shares Outstanding | 59.68 Million | 61.52 Million | 55.39 Million | 59.17 Million | 55.39 Million | 61.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 59.68 Million | 61.52 Million | 55.39 Million | 59.17 Million | 55.39 Million | 61.52 Million |
| Gross Margin | -614.93 | -462.67 | 1.00 | - | - | - |
| EBIT Margin | -4875.86 | -3140.22 | - | - | - | - |
| Profit Margin | -5516.71 | -3615.11 | -7086.00 | - | - | - |
| EBITDA | -68.26 Million | -56.52 Million | - | -53.81 Million | - | -41.02 Million |
| Earnings Before Tax Margin | -6304.50 | -4205.39 | -7069.83 | - | - | - |
300133
ROX
FNR
002689
002415
SOBHA